The Scottish Medicines Consortium (SMC) has completed its assessment of Arachis hypogaea L., semen (peanuts) (Palforzia®),and have confirmed this is not recommended for use within NHSScotland.
They concluded that treatment with Palforzia® is expected to be resource intensive with food allergy clinics needing to be reconfigured or newly setup to build capacity in providing oral immunotherapy. It was felt that there is a high degree of uncertainty regarding the proportion of individuals who would include peanuts in their diet, the proportion who would revert to avoidance only and the rate at which this occurs after cessation of Palforzia®. SMC clinical experts agreed long-term outcomes are uncertain.
Sarah Baker, Head of Health Policy and Developments, Anaphylaxis UK said:-
“We are disappointed that SMC have decided not to approve Palforzia in Scotland. Anaphylaxis UK works with many parents of children with peanut allergy, and we know it is challenging to manage. New treatment options can help to mitigate the risks of serious allergies”
Enter your details below and we’ll email you our printable guide featuring the symptoms to look out for and what to do in an emergency.
You’ll also receive our monthly Allergy Outlook email with our latest news, updates and resources straight to your inbox.